96 related articles for article (PubMed ID: 8735790)
1. Design and assessment of clinical trials on continuous infusion.
Schulman S; Martinowitz U
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S7-9. PubMed ID: 8735790
[TBL] [Abstract][Full Text] [Related]
2. Rationale and indications for continuous infusion of antihemophilic factor (factor VIII).
Goldsmith JC
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S3-6. PubMed ID: 8735789
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of factor VIII for surgery and major bleeding.
Hay CR; Doughty HI; Savidge GF
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion.
Morfini M; Messori A; Longo G
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S11-4. PubMed ID: 8735791
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic infusion regimens in the management of hemophilia.
Ljung RC
Thromb Haemost; 1999 Aug; 82(2):525-30. PubMed ID: 10605746
[TBL] [Abstract][Full Text] [Related]
6. Family issues in continuous infusion therapy with factor VIII.
Manco-Johnson MJ
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S21-5. PubMed ID: 8735793
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of coagulation factors: current opinion.
Batorova A; Martinowitz U
Curr Opin Hematol; 2006 Sep; 13(5):308-15. PubMed ID: 16888434
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and continuous infusion for hemophilia: can we afford it?
Aledort LM; Bohn RL
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S35-7. PubMed ID: 8735795
[TBL] [Abstract][Full Text] [Related]
9. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?
Martinowitz U; Schulman S
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S27-33. PubMed ID: 8735794
[TBL] [Abstract][Full Text] [Related]
10. Design of clinical studies with recombinant factor VIII. The rFactor VIII Clinical Trial Group.
Pennington JE; Schwartz RS
Semin Hematol; 1991 Apr; 28(2 Suppl 1):27-8. PubMed ID: 1908123
[No Abstract] [Full Text] [Related]
11. Single-dose pharmacokinetics of porcine factor VIII (Hyate C).
Hermans C; Owens D; Longo G; Morfini M; Lee CA
Thromb Haemost; 2002 Feb; 87(2):352-3. PubMed ID: 11858504
[No Abstract] [Full Text] [Related]
12. Stability of ADVATE, Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method, during simulated continuous infusion.
Fernandez M; Yu T; Bjornson E; Luu H; Spotts G
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):165-71. PubMed ID: 16575253
[TBL] [Abstract][Full Text] [Related]
13. [Hemophilia A with factor VIII inhibitor].
Shima M
Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
[No Abstract] [Full Text] [Related]
14. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
[TBL] [Abstract][Full Text] [Related]
15. Regimens of factor VIII administration--continuous infusion vs. bolus.
Berntorp E
Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of monoclonal antibody-purified factor VIII.
Weinstein RE; Bona RD; Rickles FR
Am J Hematol; 1991 Mar; 36(3):211-2. PubMed ID: 1899966
[TBL] [Abstract][Full Text] [Related]
17. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
den Uijl IE; Fischer K
Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
[No Abstract] [Full Text] [Related]
18. Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method.
Durisová M; Dedík L; Bátorová A; Sakalová A; Hedera J
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):217-26. PubMed ID: 9646284
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of B-domain deleted recombinant factor VIII (ReFacto) stability during simulated continuous infusion administration.
Neidhardt E; Koval R; Burke E; Warne N
Haemophilia; 2005 Jul; 11(4):319-25. PubMed ID: 16011582
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia treatment. Factor VIII inhibitors with recombinant products: prospective clinical trials.
Lusher JM
Haematologica; 2000 Oct; 85(10 Suppl):2-5; discussion 5-6. PubMed ID: 11187864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]